Tapewire

Nasdaq · USD

UCFI

CN Healthy Food Tech Group Corp.

Export transactions ↓
Tapewire entity
5989
SEC CIK
0001901203
Parsed reports
21

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2025 Filed Oct 1, 2025 01:55 UTC
Jiang ZhenjunDirector · Chairman of the Board and CEO · 10% owner
GrantCommon Stock 47,689,349 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-094291 · ownership.xml · nonDerivative · entry 1

Jiang Zhenjun · CIK 0002076533 · Director · Chairman of the Board and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Rosy Sea Holdings Limited

Disclosed balance after: 47,689,349

F1 · shares: The reported amount of shares of Common Stock were received as consideration in connection with the Business Combination Agreement, as defined in the Issuer's prospectus filed with the Securities and Exchange Commission on May 15, 2025 (the "Business Combination Agreement"). The Reporting Person is the sole shareholder and director of Rosy Sea Holdings Limited, a company incorporated and existing under the laws of the British Virgin Islands, which directly or indirectly holds substantially all of the consolidated assets and business of the Issuer.

F2 · shares: The reported amount of shares of Common Stock represents the maximum 47,888,000 that the Reporting Person would have received, assuming the public stockholders of Iron Horse Acquisition Corp. ("Iron Horse") elect to redeem all such eligible shares of Common Stock, reduced on a one-for-one basis by 198,651 shares of Common Stock that remain in Iron Horse's trust account immediately prior to the closing of the business combination contemplated by the Business Combination Agreement.

Read SEC document
September 30, 2025 Filed Oct 8, 2025 17:20 UTC
Bengochea Jose AntonioFormer Director and CEO
GrantWarrants · Derivative 2,533,500 $0.08 Strike: $11.50 $202,680.00
Disclosure

SEC source: 0001213900-25-097495 · ownership.xml · derivative · entry 3

Bengochea Jose Antonio · CIK 0002005952 · Former Director and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Bengochea SPAC Sponsors I LLC

Disclosed balance after: 2,533,500

Underlying: Common Stock · 2,533,500 shares

Expires 2030-09-30

F5 · kind: In connection with the consummation of the Business Combination and the name change, Mr. Bengochea's 1,932,000 private warrants of the Company, converted into 1,932,000 private warrants of New CFI, on a one-for-one basis, in connection with the closing of the Business Combination.

F6 · price: Based on the closing price of the public warrant of $0.075 on the Nasdaq Stock Market LLC on September 26, 2025.

Read SEC document
September 30, 2025 Filed Oct 8, 2025 17:20 UTC
Bengochea Jose AntonioFormer Director and CEO
GrantCommon Stock 500,000 $10.10 $5,050,000.00
Disclosure

SEC source: 0001213900-25-097495 · ownership.xml · nonDerivative · entry 2

Bengochea Jose Antonio · CIK 0002005952 · Former Director and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 580,000

F3 · shares: Includes 500,000 shares of common stock of the Issuer that Mr. Bengochea received as a consideration of his providing certain post-closing services to the Issuer, pursuant to a Consulting Agreement by and between himself and the Issuer.

F4 · balance_after: Based on the closing price of the common stock of $10.10 on the Nasdaq Stock Market LLC on September 26, 2025.

Read SEC document
September 30, 2025 Filed Oct 8, 2025 17:20 UTC
Bengochea Jose AntonioFormer Director and CEO
GrantCommon Stock 1,932,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-097495 · ownership.xml · nonDerivative · entry 1

Bengochea Jose Antonio · CIK 0002005952 · Former Director and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Bengochea SPAC Sponsors I LLC

Disclosed balance after: 1,932,000

F1 · kind: Pursuant to the Business Combination Agreement (as amended), dated September 27, 2024, by and among Iron Horse Acquisition Corp., a Delaware corporation (the "Company") and Rosey Sea Holdings Limited, a company incorporated and existing under the laws of the British Virgin Islands ("Rosey Sea"), the parties effected a business combination transaction ("Business Combination") on September 30, 2025. In connection with the Business Combination, the Company changed its name to "CN Healthy Food Tech Group Corp." (the "New CFI"). In connection with the consummation of the Business Combination and the name change, Jose A. Bengochea's 580,000 shares of common stock, par value $0.0001, of the Company, converted into 580,000 shares of common stock, par value $0.0001, of New CFI, on a one-for-one basis, in connection with the closing of the Business Combination.

F2 · shares: This number includes, (i) 47,500 shares held by the sponsor on behalf of Mr. Bengochea for his service as a director and officer of the Company, (ii) 701,500 shares held by Bengochea SPAC Sponsors I LLC (the "sponsor") of which 364,000 shares are held for individuals on the basis of funds paid to Bengochea Capital LLC, a limited liability company controlled solely by Mr. Bengochea and invested in the sponsor and 337,500 shares are held on behalf of Bengochea Capital LLC,; (iii) 450,000 shares, in the aggregate, held by the sponsor on behalf of the current and former directors and officers of the Company as a group (other than Mr. Bengochea), whether such shares are attributable to a director or officer on the basis of his or her service as such or on the basis of funds invested by a director or officer in Bengochea Capital LLC, and (iv) 651,000 shares held by the sponsor on behalf of a fund that invested in Bengochea Capital LLC.

Read SEC document
September 30, 2025 Filed Oct 8, 2025 21:19 UTC
Caragol William JFormer Director, CFO, and COO
GrantCommon Stock 500,000 $10.10 $5,050,000.00
Disclosure

SEC source: 0001213900-25-097491 · ownership.xml · nonDerivative · entry 2

Caragol William J · CIK 0001380465 · Former Director, CFO, and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 580,000

F3 · shares: Includes 500,000 shares of common stock of the Issuer that Mr. Caragol received as a consideration of his providing certain post-closing services to the Issuer, pursuant to a Consulting Agreement by and between himself and the Issuer.

F4 · price: Based on the closing price of the common stock of $10.10 on the Nasdaq Stock Market LLC on September 26, 2025.

Read SEC document
September 30, 2025 Filed Oct 8, 2025 21:19 UTC
Caragol William JFormer Director, CFO, and COO
GrantCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-097491 · ownership.xml · nonDerivative · entry 1

Caragol William J · CIK 0001380465 · Former Director, CFO, and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · Through Bengochea SPAC Sponsors I LLC

Disclosed balance after: 80,000

F1 · kind: Pursuant to the Business Combination Agreement (as amended), dated September 27, 2024, by and among Iron Horse Acquisition Corp., a Delaware corporation (the "Company") and Rosey Sea Holdings Limited, a company incorporated and existing under the laws of the British Virgin Islands ("Rosey Sea"), the parties effected a business combination transaction ("Business Combination") on September 30, 2025. In connection with the Business Combination, the Company changed its name to "CN Healthy Food Tech Group Corp." (the "New CFI"). In connection with the consummation of the Business Combination and the name change, William Caragol's 80,000 shares of common stock, par value $0.0001, of the Company, converted into 80,000 shares of common stock, par value $0.0001, of New CFI, on a one-for-one basis, in connection with the closing of the Business Combination.

F2 · shares: Includes 30,000 shares held by Bengochea SPAC Sponsors I LLC (the "Sponsor") on behalf of Mr. Caragol for his service as an officer of the Company as well as 50,000 shares held by the Sponsor on behalf of Mr. Caragol on the basis of funds invested by Mr. Caragol in the Sponsor.

Read SEC document
February 12, 2024 Filed Feb 25, 2025 20:27 UTC OtherCommon stock, par value $0.0001 per share 32,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-017199 · ownership.xml · nonDerivative · entry 1

Bengochea SPAC Sponsors I LLC · CIK 0002055587 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,932,000

F1 · kind: On February 12, 2024, Bengochea SPAC Sponsors I LLC, the Issuer's sponsor (the "Sponsor") forfeited 32,300 shares of common stock because the Issuer's over-allotment option was only partially exercised by the underwriters, and the remainder of the over-allotment option expired.

F1 · price: On February 12, 2024, Bengochea SPAC Sponsors I LLC, the Issuer's sponsor (the "Sponsor") forfeited 32,300 shares of common stock because the Issuer's over-allotment option was only partially exercised by the underwriters, and the remainder of the over-allotment option expired.

Read SEC document
December 29, 2023 Filed Feb 25, 2025 20:27 UTC PurchaseWarrants to purchase shares of common stock · Derivative 2,457,000 Not disclosed Strike: $11.50 Not disclosed
Disclosure

SEC source: 0001213900-25-017199 · ownership.xml · derivative · entry 2

Bengochea SPAC Sponsors I LLC · CIK 0002055587 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,457,000

Underlying: Common stock, par value $0.0001 per share · 2,457,000 shares

Expires not disclosed

F2 · price: The Sponsor purchased 2,457,000 warrants in a private placement consummated simultaneously with the closing of the IPO at a price of $1.00 per warrant. Each warrant is exercisable to purchase one share of common stock at an exercise price of $11.50. Each warrant will become exercisable 30 days after the completion of an initial business combination and will expire on the fifth anniversary of the completion of an initial business combination, or earlier upon redemption or liquidation.

F2 · derivative.exercise_date: The Sponsor purchased 2,457,000 warrants in a private placement consummated simultaneously with the closing of the IPO at a price of $1.00 per warrant. Each warrant is exercisable to purchase one share of common stock at an exercise price of $11.50. Each warrant will become exercisable 30 days after the completion of an initial business combination and will expire on the fifth anniversary of the completion of an initial business combination, or earlier upon redemption or liquidation.

F2 · derivative.expiration_date: The Sponsor purchased 2,457,000 warrants in a private placement consummated simultaneously with the closing of the IPO at a price of $1.00 per warrant. Each warrant is exercisable to purchase one share of common stock at an exercise price of $11.50. Each warrant will become exercisable 30 days after the completion of an initial business combination and will expire on the fifth anniversary of the completion of an initial business combination, or earlier upon redemption or liquidation.

F3 · ownership.direct: Mr. Jose A. Bengochea has voting and dispositive power over the securities held of record by the Sponsor. Mr. Jose A. Bengochea disclaims any beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.